(Hypertension. 1999;33:1342-1347.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
Variable Renal Atrial Natriuretic Factor Gene Expression in Hypertension
From the University of Ottawa Heart Institute, Ottawa, Ontario, Canada (T.O., A.J. de B.) and Hoechst Marion Roussel, Frankfurt am Main, Germany (W.L., B.A.S.).
Correspondence to Adolfo J. de Bold, PhD, University of Ottawa Heart Institute at the Ottawa Civic Hospital, 40 Ruskin St, Ottawa, Ontario K1Y 4W7, Canada.
Abstract—We have previously established the existence of atrial natriuretic factor (ANF) gene expression within the renal parenchyma. Neither the role nor the regulation of this extracardiac source of ANF is clearly defined. To determine whether renal ANF gene expression, similar to cardiac expression, is linked to the activity of the renin-angiotensin system (RAS), we compared renal ANF gene expression in rats after suprarenal aortic banding, a hypertension model associated with activation of RAS, and in the deoxycorticosterone acetate (DOCA)–salt model, which is characterized by depression of RAS. Renal ANF mRNA was measured with a quantitative competitive reverse transcription polymerase chain reaction method. DOCA-salt hypertension significantly reduced the expression of renal ANF. In contrast, aortic banding significantly increased renal ANF expression. In both cases, ANF gene expression in the heart increased. Ramipril treatment at 10 µg/kg of aortic-banded rats, a treatment that specifically affects local RAS but maintains hypertension, normalized renal ANF mRNA levels. Altogether, these results suggest that renal ANF gene expression is modulated by local RAS and is independent of circulating RAS and hypertension per se. The marked decrease of renal ANF mRNA in DOCA-salt hypertension suggests a pathogenic role for renal ANF gene downregulation by decreasing the sodium excretory mechanism mediated by the local expression of ANF acting on receptors found in the inner medullary collecting ducts. In aortic banding, renal ANF gene expression upregulation suggests a local compensatory function consistent with the consensus role of natriuretic peptides in the modulation of RAS, thus ameliorating the sodium-retaining effects of renal underperfusion.
Key Words: atrial natriuretic factor • renin-angiotensin system • kidney • deoxycorticosterone • hypertension, renal
This article has been cited by other articles:
 |
|
 |
|
  A. C. da Costa Goncalves, R. Leite, R. A. Fraga-Silva, S. V. Pinheiro, A. B. Reis, F. M. Reis, R. M. Touyz, R. C. Webb, N. Alenina, M. Bader, et al. Evidence that the vasodilator angiotensin-(1 7)-Mas axis plays an important role in erectile function Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2588 - H2596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-H. Wang, J. Wang, H.-H. Chang, B. A. Zand, M. Jiang, A. Nasjletti, and M. Laniado-Schwartzman Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats Am J Physiol Renal Physiol, August 1, 2003; 285(2): F295 - F302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. J. Lai, M. C. Hsieh, S. C. Hsin, S. R. Lin, J. Y. Guh, H. C. Chen, and S. J. Shin The Cellular Localization of Increased Atrial Natriuretic Peptide mRNA and Immunoreactivity in Diabetic Rat Kidneys J. Histochem. Cytochem., November 1, 2002; 50(11): 1501 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. V. d'Uscio, T. Quaschning, J. C. Burnett Jr, and T. F. Luscher Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition Hypertension, January 1, 2001; 37(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|